Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 294 results found. Search for [ drug pricing ]

Results 1 to 21 of 294
PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
August 25, 2019
In September last year, a committee on National List of Essential Medicines (NLEM) had set up sub-committees to classify medicines, medical devices, disposables, and health and hygiene products as per their criticality for the healthcare.


PTI
July 24, 2019
The growing popularity of Patanjali's products has caused discomfort among the firm's international rivals who are out to malign it by spreading lies, yoga guru Ramdev's company said on Tuesday.


PTI
July 23, 2019



PTI
June 3, 2019



PB Jayakumar
New Delhi, May 28, 2019
Domestic cancer drug sales are growing at 20 per cent annually for the past few years, while global growth is half of that


BusinessToday.In
May 27, 2019
The buzz is that Ranjan Pai-owned Manipal Hospitals has begun confirmatory due diligence on Medanta assets and an agreement is likely to be signed in the next 60 days


PTI
May 25, 2019



PTI
May 24, 2019



E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


PTI
May 21, 2019



BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


Joe C Mathew
New Delhi, April 29, 2019
New think tank to build India's case in pharma, healthcare with the world


PTI
April 1, 2019



PTI
April 1, 2019



PTI
April 1, 2019



PAGES 1 OF 15  12345